| Product Type | Impurity Standards |
| CAT. No. | MRL-S41006 |
| CAS. No. | 1808278-26-3 |
| Mol. Formula | C32H34F3N3O4 |
| Mol. Weight | 581.64 |
| Synonyms | NA |
| Chemical Name | 3-(7-Cyano-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indolin-1-yl)propyl benzoate |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Racemic Stage I of Silodosin with CAS No: 1808278-26-3 is an impurity standard of Silodosin. Silodosin is a medication primarily used to treat the symptoms of an enlarged prostate, a condition medically known as benign prostatic hyperplasia (BPH). Silodosin is classified as an alpha-1 adrenergic receptor antagonist and works by relaxing the muscles in the prostate and bladder neck which can improve urinary flow and alleviate BPH-related symptoms.Silodosin is typically taken orally in the form of capsules. Buy high quality Racemic Stage I of Silodosin from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Racemic Stage I of Silodosin